T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...
(RTTNews) - Coherus BioSciences, Inc. (CHRS), Wednesday announced final data from its Phase 2 study evaluating casdozokitug in combination with atezolizumab and bevacizumab in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback